The target enzymes role in leukaemia was discovered by researchers at the University of Birmingham.

CRT groups up with The University of Auckland to find novel treatments for cancer UK-NZ collaboration to home in on fresh anti-cancer drug for leukaemiaCancer Analysis Technology – Cancer Study UK’s development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of brand-new molecular targeted compounds for the treating leukaemia. Scientists based at the Auckland Tumor Society Research Centre and CRT’s Discovery Laboratories in London and Cambridge will focus on developing a treatment which will target an enzyme that is from the growth and advancement of leukaemia cells. The target enzyme’s role in leukaemia was discovered by researchers at the University of Birmingham, funded by the charity Leukaemia & Lymphoma Analysis.As the study had not been specifically designed to study survival rates, our results show a statistically significant decrease in individuals given the drug versus those who received placebo, said John Glaspy, M.D., professor at the University of California, LA School of Medicine. Since erythropoietic agents are sometimes used in the U. S. To take care of anemia and reduce transfusion risk in patients not on chemotherapy, these total results are of concern to the study and scientific cancer communities. The trial was made to examine the ability of darbepoetin to reduce the need for blood transfusions in patients with active cancer not undergoing chemotherapy.

Other entries from category "tomography":

Random entries